Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Albemarle Corp buy Stephens

Start price
€121.74
19.12.25 / 50%
Target price
-
19.12.26
Performance (%)
12.99%
Price
€137.56
10:55
Summary
This prediction is currently active. The prediction currently has a performance of 12.99%. This prediction currently runs until 19.12.26. The prediction end date can be changed by Stephens at any time. Stephens has 50% into this prediction

Albemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.

Performance without dividends (%)
Name 1w
Albemarle Corp 9.734%
iShares Core DAX® 1.822%
iShares Nasdaq 100 1.093%
iShares Nikkei 225® 3.042%
iShares S&P 500 1.247%

Comments by Stephens for this prediction

In the thread Albemarle Corp diskutieren

Albemarle (NYSE:ALB) had its "outperform" rating reaffirmed by analysts at Stephens.
Ratings data for ALB provided by MarketBeat